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Brucella spp. cause undulant fever in humans and brucellosis in variety of other animals.
Both innate and adaptive immunity have been shown to be important in controlling
Brucella infection. Toll-like receptors (TLRs) represent a group of pattern recognition
receptors (PRRs) that play critical roles in the host innate immune response, as well
as development of adaptive immunity. In the current report, we investigated the role
of TLR signaling in the clearance of Brucella and development of adaptive immunity in
TLR2−/−, TLR4−/−, or MyD88−/− mice following aerosol exposure to B. melitensis 16M.
Consistent with previous reports, MyD88 is required for efficient clearance of Brucella
from all three organs (lung, spleen, and liver). The results reveal Th2-skewed immune
responses in TLR2−/− mice late in infection and support a TLR2 requirement for efficient
clearance of Brucella from the lungs, but not from the spleen or liver. Similarly, TLR4 is
required for efficient clearance of Brucella from the lung, but exhibits a minor contribution
to clearance from the spleen and no demonstrable contribution to clearance from the
liver. Lymphocyte proliferation assays suggest that the TLRs are not involved in the
development of cell-mediated memory response to Brucella antigen. Antibody detection
reveals that TLR2 and 4 are required to generate early antigen-specific IgG, but not during
the late stages of infection. TLR2 and 4 are only transiently required for IgM production
and not at all for IgA production. In contrast, MyD88 is essential for antigen specific IgG
production late in infection, but is not required for IgM generation over the course of
infection. Surprisingly, despite the prominent role for MyD88 in clearance from all tissues,
MyD88-knockout mice express significantly higher levels of serum IgA. These results
confirm the important role of MyD88 in controlling infection in the spleen while providing
evidence of a prominent contribution to protection in other tissues. In addition, although
TLR4 and TLR2 contribute little to control of spleen infection, a significant contribution to
clearance of lung infection is described.
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INTRODUCTION
The genus Brucella is a group of Gram-negative, facultative intra-
cellular bacteria that cause brucellosis, a reproductive disease in
ruminants, and undulating fever in humans. Brucellosis is one
of the most important worldwide zoonotic diseases. Ten species
have been identified to date, three of which, including B. meliten-
sis, B. abortus, and B. suis are virulent in humans and represent
a significant threat to public health (Atluri et al., 2011). Humans
often become infected following inhalation of particles carrying
the bacteria or consumption of dairy products contaminated with
the organism. Although vaccination is used to successfully reduce
the spread of disease, the risk remains high in underdeveloped
nations. There are currently no vaccines available that are safe for
use in humans, and although generally effective, antibiotic treat-
ments do not always prevent disease recrudescence. As a result
of these factors and concern over their potential weaponization,
NIH and the CDC/USDA have classified these three species as
category B agents.
Both innate and adaptive immunity have been described as
contributing to the control of Brucella infection (Baldwin and
Parent, 2002; Dornand et al., 2002; Baldwin and Goenka, 2006).
The role of innate immunity against infection by this pathogen
has drawn recent attention as a result of awareness of the role of
innate immunity in the establishment of infection and the devel-
opment of adaptive immunity (Weiss et al., 2005; Oliveira et al.,
2011). In contrast, adaptive immunity, including cell-mediated
and humoral responses, has been the prominent focus of Brucella
research over the past few decades.
The innate immune system is composed of a variety of
cellular and humoral components, which are the first line of
the host defense against invading pathogens. Recognition relies
on pattern recognition receptors (PRRs) expressed on/in the
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cellular components of the innate immune system. Toll-like
receptors (TLRs) are the best characterized PRRs. Receptor-
ligand interaction via TLRs induces the production of antimi-
crobial peptides and proinflammatory cytokines through NF-κB,
mitogen-activated protein kinase (MAPK) and other signaling
pathways (Kawai and Akira, 2006). As a result, TLR signaling
is critical to development of the host innate immune response,
including recruitment of dendritic cells (DCs) and T effector cells,
and upregulation of MHC I and II on antigen presenting cells
(APCs) and by extension adaptive immunity against infection. 10
TLRs in human and 13 in the mouse have been identified to date
(Kawai and Akira, 2006). TLR2, TLR4, TLR5, and TLR9 recog-
nizing lipopeptide, lipopolysaccharides, flagellin and CpG DNA,
respectively, are known to be important in controlling bacterial
infections. With the exception of TLR3, the TLRs require the
adapter molecule myeloid differentiation factor 88 (MyD88) for
signal transduction (Kawai andAkira, 2007). As expected, MyD88
have been shown to be essential for clearance of Brucella infection
from mice (Weiss et al., 2005; Copin et al., 2007; Macedo et al.,
2008).
Several groups have investigated the contribution of TLR sig-
naling to innate immunity against Brucella infection in the mouse
model. The consensus opinion is that TLR2 is not required to con-
trol Brucella infection in the mouse (Campos et al., 2004; Copin
et al., 2007). However, TLR2 has been shown to be important for
cytokine production (Huang et al., 2003; Giambartolomei et al.,
2004; Weiss et al., 2005; Macedo et al., 2008; Zwerdling et al.,
2008), MHC-II expression (Barrionuevo et al., 2008) and down
regulation of the type I receptor for the Fc portion of IgG (FcγRI,
CD64) (Barrionuevo et al., 2011) in tissue culture.
The role of TLR4 in Brucella infection remains controversial.
Some studies suggest that TLR4 is required to control Brucella
replication in the mouse (Campos et al., 2004; Copin et al.,
2007; Macedo et al., 2008); others indicate that TLR4 is not
involved (Weiss et al., 2005; Barquero-Calvo et al., 2007). The
use of different Brucella strains/species in these experiments may
account for the observed differences. The influence of the route
of infection on the role of TLRs in studies with other pathogens
suggests a need to do so with brucellosis, as is the role of
TLR-mediated innate immunity in the development of adaptive
immune response. These studies employed intraperitoneal (i.p.)
inoculation, which is not a typical route for Brucella infection.
As a result of these reports, the consensus of scientific opinion
is that MyD88 contributes significantly to the control of Brucella
infection while TLR-based signaling plays a lesser role at best. The
absence of any role for TLR signaling is consistent with results
indicating that the Brucella protein TcpB interrupts TLR–based
signaling by promoting degradation of MyD88 adaptor like pro-
tein, MAL (Chaudhary et al., 2012), and modification of Brucella
LPS reduces agonist activity (Duenas et al., 2004). However, these
studies have been restricted to an atypical route of exposure, and
the potential for differential TLR expression associated with dif-
ferent tissues has not been considered (Juarez et al., 2010). Since
inhalation represents a major concern to public health, experi-
ments were undertaken to determine the role of TLR signaling
in the control of Brucella infection following aerosol exposure.
The current study, investigates the roles of TLR2, TLR4, and
MyD88 in clearance of Brucella following respiratory exposure
and development of adaptive immune response against Brucella.
Since the mucosal/respiratory system is the primary portal of
entry for human infection documented in many laboratory inci-
dents and relevant to biothreats, it is important to understand
the pathogenesis and immune responses resulting from aerosol
exposure.
Since TLR signaling is an important component bridging
innate and adaptive immunity (Iwasaki and Medzhitov, 2004),
failure to clear Brucella from organs by TLR signaling deficient
mice could be due to defects in the development of adaptive
immunity. To test this hypothesis, we determined cellular- and
humoral-mediated adaptive immunity in these TLR knockout
mice following Brucella infection. The results reveal that TLR sig-
naling exhibits significant differences in control and clearance of
Brucella from selected tissues and in the associated development
of an adaptive immune response.
MATERIALS ANDMETHODS
BACTERIAL STRAIN AND GROWTH CONDITIONS
The bacterial strain used in these experiments, B. melitensis
16M was obtained from ATCC (#23456) and recovered from an
aborted goat fetus. Bacterial cultures were prepared as previously
described (Pei and Ficht, 2004). Briefly, B. melitensis 16M was
cultured in TSB for 24 h, pelleted by centrifugation at 20,000×g,
washed with and resuspended in PBS (pH 7.4) at a density of
approximately 5 × 109 CFU/ml (Kahl-McDonagh et al., 2007).
MOUSE MODEL OF INFECTION
Breeding pairs of TLR2−/−, TLR4−/−, andMyD88−/− mice were
obtained from Dr. S. Akira (Osaka University, Osaka, Japan) via
Dr. Michael Berton (University of Texas at San Antonio, San
Antonio, TX) and colonies maintained by Comparative Medicine
Program (CMP) personnel at TAMU. C57BL/6 control mice were
purchased from Jackson Laboratory. All mice were housed in
BSL-3 suite in the CMP at Texas A&M University. Mice of both
sexes between 8 and 12 weeks old were used in the experiments.
Euthanasia was performed using carbon dioxide inhalation. All
personnel working with animals received training in rodent han-
dling and euthanasia via the CMP. All animal work was performed
in compliance with the Public Health Service (PHS) Policy on
Humane Care and Use of Laboratory Animals as described by
the National Research Council’s Institute for Laboratory Animal
Research (ILAR) Guide for the Care and Use of Laboratory
Animals.
AEROSOL EXPOSURE OF MICE
Aerosols were generated via nebulization of a Brucella suspension
(∼5 × 109 CFU/ml in PBS) into a Madison Chamber (Madison,
Wisconsin) according to the manufacturer’s instructions (Kahl-
McDonagh et al., 2007). The aerosol chamber was located in
a biosafety level 3 (BSL3) facility in the Laboratory Animal
Research and Resources (LARR) building staffed and managed by
the CMP at Texas A&M University. To assure personal safety, the
principal investigator implemented a strict safety protocol, and
all procedures were approved by the IBC and IACUC. Following
aerosol exposure, one group of mice (n = 5) were immediately
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euthanized via carbon dioxide inhalation and the lungs collected
to determine the infecting dose (Kahl-McDonagh et al., 2007).
At 1, 2, 4, 6, 8, and 10 weeks after exposure, mice were eutha-
nized and lung, spleen and liver were collected and homogenized
in 1ml each of sterile water containing 0.5% (v/v) Tween-20. One
hundred microliters of appropriate dilution of the homogenized
tissue were plated on Farrell’s selective medium plates followed by
incubation at 37◦C for at least 3 days. The experimental limit of
detection was determined to be 10 CFU per lung, spleen or gram
of live, and the results described represent the accumulated data
from 4 independent aerosol exposures.
LYMPHOCYTE PROLIFERATION ASSAY
At 8-week post infection (p.i.), one-half of the spleen from each
euthanized mouse was used to produce single cell suspensions as
previously described. The cell density was adjusted to 2 × 106
per ml using complete RPMI-1640 containing 10% (v/v) heat-
inactivated FBS, 1mM non-essential amino acid, 100μg/ml of
penicillin and 100U/ml streptomycin. The cell suspension was
dispensed to 24-well plates with 1ml/well and stimulated with
heat killed Brucella (HKB) or ConA (2μg/ml) for three days.
Following stimulation, supernatants were collected and cytokine
synthesis characterized. Cells collected from 100μl of the sus-
pension were lysed using 1% (v/v) Triton X-100, and the LDH
released from live cells was determined using CytoTox 96™
Nonradioactive Cytotoxicity Assay kit (Promega) following the
manufacturer’s instructions.
CYTOKINE ELISA
IFN-γ levels in the culture supernatants were determined 72 h
post stimulation using sandwich ELISA kits (PeproTech Inc.,
Rocky Hill, NJ) according to the manufacturer’s instructions (Pei
et al., 2008).
ANTI-BRUCELLA ANTIBODY DETECTION
Blood samples were collected just prior to euthanization from
mice at 1, 2, 4, 6, 8, and 10 weeks post exposure. Sera were sep-
arated and anti-Brucella antibodies, including IgG, IgG1, IgG2a,
IgM, and IgA were evaluated using ELISA. ELISA plates (Nunc)
were coated with B. melitensis 16M cell lysate. Briefly, 100μl of
1μg/ml lysate in bicarbonate/carbonate buffer (2.93 g NaHCO3,
1.59 g Na2CO3, 0.203 g MgCl2 in 1 L of distilled water, pH 9.6)
was added to microtiter wells (96 wells/plate) and incubated
overnight at 4◦C (Pei and Collisson, 2005). Non-specific binding
was blocked via incubation with 5% (w/v) non-fat milk in PBS
for 1 h at room temperature. The antigen-coated wells were incu-
bated 2 h at room temperature (25◦C) with mouse sera diluted
in PBS (pH 7.4) containing 0.05% (v/v) Tween-20 (PBS-T) 200
times for IgG1, IgG2a, IgM, IgA detection or 1000 times for IgG
detection. The plates were then incubated with HRP-conjugated
goat anti-mouse immunoglobulins (IgG1, IgG2a, IgM, IgA, and
IgG from Kirkegard-Perry Labs (KPL) for 1 h at room tempera-
ture. The wells were washed with PBS-T between steps to remove
any unboundmaterials. Color development followed the addition
of 100μl of TMB substrate KPL. The reaction was terminated by
the addition of 50μl of stop buffer (1 M H2SO4) and OD450 was
determined using an ELISA reader (Bio-Rad).
STATISTICAL ANALYSIS
Statistical significance was determined using one-way ANOVA or
Student’s t-test. P-values<0.05∗ and<0.01∗∗ were considered to
be significant.
RESULTS
THE ROLE OF TLR SIGNALING IN CLEARANCE OF BRUCELLA
FROM THE LUNG
In these experiments, the infecting dose determined using lungs
collected from control C57BL/6 mice (n = 5) immediately fol-
lowing challenge is 4.26 ± 0.28 log CFU/mouse, which is con-
sistent with a previous report (Kahl-McDonagh et al., 2007).
Bacterial load recovered from the lungs of TLR2−/−, TLR4−/−,
and MyD88−/− mice during the first two weeks following expo-
sure is not significantly different from the C57BL/6 control
mice (Figure 1, panels W1–2), indicating that TLR2, TLR4, and
MyD88 are not required to clear lung infection early. A significant
difference in bacterial burden is detectable by week 4 and extends
through week 10, indicating that the contribution of TLR2, TLR4,
andMyD88 to the control of Brucella infection in the lungs occurs
via adaptive immunity (Figure 1). By week 4 p.i., there was a sig-
nificant difference in the clearance of the organism from each of
the knockouts. This pattern persisted through week 10, although
significance is lost due to the reduction in the number of ani-
mals available at this time point. The absence of MyD88 appears
to have a greater impact on the clearance of infection from the
lungs over this period, as the bacterial burden in the lungs of
MyD88−/− mice is significantly higher than that in TLR2−/− and
TLR4−/− mice by week 8 p.i. (Figure 1, panel W8). The kinetics
of Brucella clearance from the lungs is summarized in Figure 1K,
and taken together, these results indicate that TLR2, TLR4, and
MyD88 contribute to Brucella clearance from the lungs following
aerosol challenge.
THE ROLE OF TLR SIGNALING IN BRUCELLA CLEARANCE FROM
THE SPLEEN
Infection and the kinetics of clearance of Brucella from the spleens
of mice is notably different from that observed in the lung.
Initially, the organism exhibits a delay in systemic distribution
to the spleen that requires up to 4 weeks to achieve maximum
burden. The delay in systemic spread of infection is evident in
the spleen and less dramatically in the liver (see below), with
bacterial burden in 9 of 13 spleens from TLR4−/− and 10 of 13
from MyD88−/− mice below the detection limit (10 cfu/spleen).
This compares with a delay in only 1 of 17 TLR2−/− mice
and 5 of 20 C57BL/6 mice. The MyD88−/− knockout appears
to have a reduced ability to control the infection as evidenced
by the significant difference in spleen colonization by week 4
(Figure 2, panel W4). Once established infection proceeds sim-
ilarly, although the MyD88−/− and TLR4−/− mice exhibit a
delay in clearance relative to the TLR2−/− and C57BL6 mice
(Figure 2, panels W6–10). Systemic spread and the clearance of
infection from the spleen is unaffected by the loss of TLR2, with
no significant difference observed between the TLR2−/−/− and
wild-type mice over the course of infection (Figure 2, panels
W1–10). In contrast, both TLR4−/− and MyD88−/− mice exhib-
ited early delays in systemic spread of infection during the first
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FIGURE 1 | TLR signaling is required for efficient clearance of Brucella
from the lungs. Groups of TLR2−/−, TLR4−/−, MyD88−/− and C57BL/6 mice
were aerosol exposed to B. melitensis 16M. The lungs were collected at
weeks 1 (panel W1), 2 (panel W2), 4 (panel W4), 6 (panel W6), 8 (panel W8),
and 10 (panel W10) post infection, and bacterial loads were determined. The
data were pooled from four separate experiments. The results were analyzed
using one-way ANOVA. ∗P < 0.05, ∗∗P < 0.01. The line graph (panel K)
illustrates the kinetics of bacterial clearance from the lungs. Error bars, S.E.
week, which is accompanied by a delay in clearance at later times.
Again, the exaggerated decline observed between weeks 8 and
10 in TLR4−/− mice may be an artifact of the reduced animals
numbers.
THE ROLE OF TLR SIGNALING IN BRUCELLA CLEARANCE FROM
THE LIVER
Similar to the results described for the spleen, systemic spread of
the organism to the liver is delayed in TLR4−/− and MyD88−/−
mice, and is associated with a corresponding delay in the clear-
ance of infection. Here again, TLR2−/− mice are indistinguish-
able from control mice in the ability to restrict systemic infection
(Figures 2 and 3). As observed in the spleen, the capacity to con-
trol infection is most dramatically affected in theMyD88−/− mice
(Figure 3, panels W1–10). From week 2 and onward, TLR2−/−
and TLR4−/− mice controlled infection and cleared the organ-
isms from the livers indistinguishably from the C57BL/6 mice
(Figure 3, panel W10). Taken together, these results reveal that, in
the mouse liver; (1) TLR2 and TLR4 are not required to control
infection or clearance; (2) the absence of TLR4 reduces accumu-
lation of Brucella in the liver, but has little effect on late stage
clearance; (3) MyD88 is critical in early control and late clearance
of the organism.
ADAPTIVE CELL-MEDIATED IMMUNE RESPONSE FOLLOWING
AEROSOL CHALLENGEWITH BRUCELLA
To determine the development of cell-mediated immunity, the
splenocytes collected at 8 weeks p.i. from knockout and control
mice are stimulated with Brucella antigen ex vivo. Using an LDH
release assay to measure lymphocyte proliferation, no significant
differences in proliferation was detected for TLR2−/−, TLR4−/−,
MyD88−/− and control C57BL/6 mice (Figure 4A). This result
indicates that cell-mediated adaptive immunity against Brucella
is unimpaired in these knockout mice. Consistent with the results
of the lymphocyte proliferation assay, IFN-γ levels detected in
splenocyte supernatants collected from the knockout mice are not
significantly different from C57BL/6 mice (Figure 4B).
ADAPTIVE HUMORAL RESPONSE FOLLOWING AEROSOL
CHALLENGEWITH BRUCELLA
To determine the role of TLR signaling in antibody production
and isotype switching, anti-Brucella IgM, IgG, IgG1, IgG2a, and
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FIGURE 2 | TLR4 and MyD88 are required to control and clear Brucella
from the spleens. Groups of TLR2−/−, TLR4−/−, MyD88−/− and C57BL/6
mice were aerosol exposed to B. melitensis 16M. The spleens were collected
at weeks 1 (panelW1), 2 (panelW2), 4 (panelW4), 6 (panelW6), 8 (panelW8),
and 10 (panel W10) post infection, and bacterial loads were determined. The
data were pooled from four separate experiments. The results were analyzed
using one-way ANOVA. ∗P < 0.05, ∗∗P < 0.01. The line graph (panel K)
illustrates the kinetics of bacterial clearance from the lungs. Error bars, S.E.
IgA responses were determined following aerosol infection. The
results presented reveal detectable levels of IgM by 2 weeks p.i.
that peaks by 4 weeks p.i. (Figure 5, panel A). IgM levels begin
to decline in the MyD88−/− and C57BL/6 mice at 4 weeks p.i.
while, IgM levels in the TLR2−/− and TLR4−/− mice plateau at 4
weeks with a gradual decline by 10 weeks p.i. Any requirement for
TLR2 and TLR4 in IgM production is transient (only at 4 weeks
p.i.). and IgM levels were never significantly different between
MyD88−/− and C57BL/6 mice throughout the experiment.
Total Brucella-specific IgG in wild-type mice is detectable
starting 4 weeks post-infection (Figure 5, panel B), and increases
continuously over the next 6 weeks. In contrast, elevation of the
Brucella specific IgG levels is delayed in all of the knockout mice.
Comparison among the groups revealed that, between weeks 4
and 8 p.i., IgG levels in TLR2−/− and TLR4−/− mice are signif-
icantly lower than that observed in the C57BL/6 mice. IgG levels
increase in TLR4−/− and TLR2−/− mice by 10 weeks p.i. to lev-
els that are not significantly different from the control C57BL/6
mice. In contrast, IgG levels in MyD88−/− mice exhibit a signifi-
cant reduction in titer over the course of infection. Serum IgA is
not detected in the TLR2−/− and TLR4−/− mice, nor in C57BL/6
mice out to week 10 (Figure 5, panel C). Interestingly, serum IgA
is prominent in the sera of MyD88−/− mice and continuously
increases over the course of the experiment.
Recent studies have shown that TLRs play a critical role in
determining the fate of naive T cells, directing them toward either
Th1 or Th2 responses (Dabbagh and Lewis, 2003; Xu et al.,
2004). To characterize the role of TLR signaling in determin-
ing a Th1 or Th2 response, IgG1 (Th2) and IgG2a (Th1) levels
and the IgG1/IgG2a ratio are calculated following Brucella aerosol
exposure. IgG1 and IgG2a production are above background lev-
els only 8 weeks p.i. (Figure 5, panels D and E). By week 10,
TLR2 and C57BL/6 mice produce significantly elevated levels of
IgG1 (Figure 5, panel D) indicating TLR2 is not required for
IgG1 production. In contrast, IgG1 levels in TLR4 and MyD88
knockout mice are significantly reduced, indicating TLR4 and
MyD88 are essential for IgG1 production (Figure 5, panel D).
Relatively low levels of IgG2a are present at 10 weeks p.i. in all
groups, but IgG2a levels in TLR2 and MyD88 knockout mice
are significantly reduced relative to control mice. IgG1/IgG2a
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FIGURE 3 | MyD88 is required for clearance of Brucella from the livers.
Groups of TLR2−/−, TLR4−/−, MyD88−/−, and C57BL/6 mice were aerosol
exposed to B. melitensis 16M. The livers were collected at weeks 1 (panel
W1), 2 (panel W2), 4 (panel W4), 6 (panel W6), 8 (panel W8) and 10 (panel
W10) post infection, and bacterial loads were detected. The data were pooled
from four separate experiments. The results were analyzed using one-way
ANOVA. ∗P < 0.05, ∗∗P < 0.01. The line graph (panel K) illustrates the
kinetics of bacterial clearance from the lungs. Error bars, S.E.
FIGURE 4 | TLR signaling is not essential for development of
cellular-mediated adaptive immunity. Splenocytes collected from
TLR2−/−, TLR4−/−, MyD88−/− and C57BL/6 mice at 8 weeks p.i. were
stimulated with heat killed Brucella (HKB) or Con A for 3 days. Lymphocyte
proliferation was determined using LDH release assay (A). IFN-γ levels in
the culture supernatants were determined via ELISA (B). Data shown
was a representative of three independent experiments. Error
bars, S.E.
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FIGURE 5 | Different TLRs play different roles in eliciting antibody
responses after aerosol challenge. Groups of TLR2−/−, TLR4−/−,
MyD88−/− and C57BL/6 mice were aerosol exposed to B. melitensis 16M.
Blood samples were collected at 1, 2, 4, 6, 8, and 10 weeks post infection
and sera were isolated. Immunoglobulin levels IgM (panel A), IgG (panel B),
IgA (panel C), IgG1 (panel D), IgG2a (panel E) in the sera were detected using
ELISA. IgG1/IgG2a ratio is illustrated (panel F). Error bars, S.E. ∗P < 0.05
when compared to C57BL/6.
ratios suggesting Th2-skewed immune responses are induced in
TLR2−/−, MyD88−/− and C57BL/6 mice. The Th2 response
in TLR2 knockout mice is significantly elevated compared to
wild type mice at 10 weeks p.i. (Figure 5, panel F), indicat-
ing TLR2 interactions suppress Th2 response following aerosol
infection.
DISCUSSION
The kinetics of Brucella spp. clearance from infected mice differs
depending on the genetic background of the strain. In C57BL/6
mice, infection is at or below the limit of detection in the liver as
early as 6 weeks p.i. or by 8 weeks in the lung (Figures 1 and 3).
In contrast, these same organs in BALB/c mice contain persis-
tent levels of organism 8 weeks p.i. and beyond (Kahl-McDonagh
et al., 2007). These results are consistent with previous reports
describing enhanced sensitivity of BALB/c mice to Brucella infec-
tion following i.p. inoculation (Copin et al., 2007), confirming
the expected immunological outcome despite the use of different
routes of inoculation. One explanation for the improved clear-
ance from C57BL6 mice is generation of a TH1-skewed immune
response as opposed to a TH2-skewed response in BALB/c mice
(Watanabe et al., 2004).
TLR activation induces the maturation of APCs, enhances
antigen presentation, up-regulation of co-stimulatory molecules
and cytokine production. Cytokine profiles produced by APCs
control CD4+ T cell differentiation into either TH1 or TH2
cells. Engagement of different TLRs is expected to affect cytokine
production, with significant effect on CD4+ T cell differentia-
tion (Dabbagh and Lewis, 2003). Previous studies have shown
that Brucella infection induces mainly a TH1 response during
acute disease (Agranovich et al., 1999; Pasquali et al., 2001;
Giambartolomei et al., 2002; Rafiei et al., 2006; Khatun et al.,
2009).
It is clear that TLR signaling plays a critical role in the acti-
vation of the host innate immune response, including cytokine
and chemokine secretion and up-regulation of co-stimulatory
molecules in APCs (Kawai and Akira, 2006). Recent studies have
shown that these activations indirectly affect the development of
adaptive immunity (Iwasaki and Medzhitov, 2010). In addition,
it has been demonstrated that functional TLRs are expressed on
various T and B cell subsets (Bekeredjian-Ding and Jego, 2009;
Booth et al., 2011; Kulkarni et al., 2011). For example, functional
expression of TLRs has been extensively investigated on γδ-T cells
(Wesch et al., 2011) that have been shown to be important in con-
trolling Brucella infection (Bertotto et al., 1993; Ottones et al.,
2000). Interaction of TLRs with their respective microbial lig-
ands provides a third signal for B cell activation, which is essential
for optimal antigen-specific antibody production and class switch
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recombination (Bekeredjian-Ding and Jego, 2009; Booth et al.,
2011).
Brucella are adept at inhibiting the host immune response.
Brucella virulence derives from expression of an LPS with reduced
agonist activity that limits activation of innate immunity and
development of an effective adaptive response that promotes
invasion and establishment of a replicative niche. In addition,
Brucella express a protein TcpB (or Btp1) that restricts the proin-
flammatory response by interfering with MyD88 function. The
result is enhanced degradation of MAL (MyD88-adapter-like
protein) and restricted expression of NFκB. However, our cur-
rent results indicate infection varies in different tissues, and that
this variation is attributable in part to various PRRs, including
TLR2, TLR4, and downstream signaling partners, like MyD88.
Interference with TLR signaling by the organism has been
described in numerous studies, as has the prominent contribu-
tion of MyD88 in limiting infection. The results reported here
confirm the importance of MyD88 in the control of infection and
extend those findings to include three tissues; spleen, liver and
lung. In addition, the experiments performed confirm previous
findings concerning the lack of significant contribution of TLR4
and TLR2 with regard to spleen (and liver) infection, but reveal
their significant contribution preventing lung infection.
In an effort to explain the control exerted by each of these
host factors, an evaluation was made of the corresponding
immune response. Since cellular immunity is critical in control-
ling Brucella infection, splenocytes were used to characterize the
role of TLR2, TLR4 and MyD88 in the development of cell-
mediated adaptive immunity against Brucella. Finding that the
loss of TLR2, TLR4 and MyD88 had no demonstrable effect
on the development of memory T cell response against Brucella
infection was initially a surprise (Figure 4). However, recent
experiments have revealed a disruption of TLR signaling result-
ing from enhanced degradation of MyD88-adaptor like protein
(MAL) that is consistent with previous reports documenting a
minimal role for TLR signaling in memory T cell development
against other viral and bacterial infections (Way et al., 2003;
Fremond et al., 2004; Heer et al., 2007; Seibert et al., 2010;
McBride et al., 2011). These results are also in agreement with
a recent study showing that IRAK4 (interleukin-1 receptor asso-
ciated kinase 4), one of the kinases recruited by MyD88 upon
stimulation, is not required for generation of CD4+ and CD8+
T cells producing IFN-γ in the late stage of Brucella infection
(Oliveira et al., 2011). These results suggest that TLR-independent
signaling is likely involved in the development of cellular adaptive
immunity against Brucella.
The contribution of humoral immunity to the outcome of
Brucella infection is controversial. IgM may enhance opsonic
uptake or the activity of complement. However, the differences in
IgM production between knockouts are only transitory and have
no correlation with differences in immune clearance. In general,
IgG levels are significantly reduced in each of the knockout mice.
However, the effect in the TLR4 and TLR2 knockouts is tran-
sient, while reduced IgG levels are consistently observed in the
absence of MyD88 function. A second marker associated with the
loss of MyD88 is the significant level of circulating IgA observed
in the MyD88 knockout mice. Surprisingly, serum IgA levels were
elevated in MyD88−/− mice, but not in TLR2−/− and TLR4−/−
mice following Brucella infection, suggesting that the IgA class
switch recombination or secretion is enhanced in MyD88 knock-
out mice. Alternatively, higher Brucella burden in the lung con-
stantly stimulates IgA secretion. However, this hypothesis is not
supported by the fact that serum IgA is not detected in the TLR2
and TLR4 knockout mice despite similar levels of bacterial bur-
den in the lung. In fact, this phenomenon has been previously
reported in MyD88−/− mice orally vaccinated with attenuated
Salmonella expressing a Streptococcus pneumoniae surface antigen
(Park et al., 2008). It could prove useful to understand the biolog-
ical mechanism involved and its potential application to vaccine
design. The contribution of either elevated IgA or suppressed IgG
to the inability of MyD88 knockouts to control infection is under
investigation.
Since a reduction in the IgG1/IgG2a ratio is associated with the
development of a TH1 response and protection against Brucella
infection, IgG, IgG1 and IgG2a levels were characterized in TLR2,
TLR4 andMyD88 following aerosol exposure (Figure 5, panel F).
The results reveal a significant contribution of TLR4 and MyD88
to IgG1 production and the importance of TLR2 and MyD88 to
IgG2a production. Examination of the IgG1/IgG2a ratio suggests
the dependence of a protective TH1 response on expression of
MyD88 and TLR2, but not TLR4. This is not a totally unexpected
result since the Brucella LPS, and/or TcpB primarily exert their
influence on TLR4-based signaling. The contribution of MyD88
and TLR2 to protective immune response as determined by the
reduced bacterial burden in selected tissues is borne out in previ-
ous discussion. To reiterate, MyD88−/− exhibits significant delays
in clearance from all three tissues examined; TLR2 and TLR4
contribute to clearance from the lung alone.
The importance of TLR signaling in the induction of antibody
production remains controversial. In one such study, it was shown
that TLR is not required for mice to generate robust antibody
response (Gavin et al., 2006). Other researchers report that TLR
signaling is critical for antibody production and isotype switching
(Pasare andMedzhitov, 2005; Heer et al., 2007). A recent study by
Weiss et al. show that TLR2, TLR4, TLR2/TLR4, and MyD88 are
not required for anti-Brucella IgG production (Weiss et al., 2005).
In contrast, our results reveal that production of Brucella specific
IgG is delayed in TLR2 and TLR4 knockout mice and impaired
in MyD88 knockout mice. Possible reasons for the discrepancies
include the use of different Brucella species, B. melitensis 16M
vs B. abortus S19, differences in virulence and different routes of
inoculation (aerosol exposure vs. intraperitoneal injection). Since
IgM production is not affected by MyD88 deficiency and only
transiently affected by TLR2 and TLR4 absence, we conclude that
TLR2, TLR4 andMyD88 are critical for IgG class switch recombi-
nation, whichmight be critical to the control of Brucella infection,
and should be considered when Brucella designing vaccines.
In our current report, we have clearly demonstrated that TLR2
and TLR4 are critical to clearance of Brucella infection from the
lung, although less prominently than MyD88. This contrasts sig-
nificantly with the clearance profile for the spleen and liver and
may arise as a result of differences in the TLR expression pat-
tern or levels reported for different tissues (Nishimura and Naito,
2005). It should be noted that based on results of previous studies
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following i.p. inoculation in which only the spleens were exam-
ined, it was concluded that Brucella infection was unaffected by
the loss of TLR2, however, bacterial load in the lungs and livers
were not determined in these studies. (Campos et al., 2004; Weiss
et al., 2005; Copin et al., 2007; Macedo et al., 2008). In agreement
with previous studies, the results confirmMyD88 as a critical fac-
tor in the control of Brucella infection in the spleen (Campos
et al., 2004; Weiss et al., 2005; Barquero-Calvo et al., 2007; Copin
et al., 2007; Macedo et al., 2008). However, caution is warranted
in interpretation of the significance of host factors based on the
analysis of a single tissue. Recent results in our laboratory indi-
cate that Brucella may be recovered from the lung following i.p.
inoculation, indicating a need to consider persistence in this tissue
irrespective of the route of infection.
Another unexpected observation in this study was the delay in
infection of the spleens and livers of TLR4−/− and MyD88−/−
mice 1–2 weeks post-inoculation. These results suggest that TLR4
and MyD88 play significant roles in mediating Brucella dissem-
ination from the lungs to other tissues, which is consistent with
a previous observation indicating a role for TLR4 in the uptake
of smooth Brucella by macrophage (Pei et al., 2008), and that
translocation of bacteria across mucosal or intestinal barriers is
mediated by TLR4 (Neal et al., 2006). Evaluation of Brucella infec-
tion dynamics derived from different routes of entry during the
first week post aerosol exposure may be expected to confirm these
results and potentially suggest post-exposure treatments.
Over millions of year’s co-evolution between host and
pathogen have resulted in strategies to survive in the host and
cause disease presumably without eliminating the host entirely.
Recent studies reveal that bacteria exploit the host TLR pathway,
resulting either in enhanced virulence or immune suppression
(Arpaia et al., 2011; Round et al., 2011). Our previous study
has shown that Brucella can use TLR4 to gain entry into the
host cells (Pei et al., 2008). It is possible that Brucella inhibit
IgA class switch recombination or secretion via MyD88 by an
unknown mechanism in order to initiate infection through
mucosal surfaces.
Overall, our data demonstrate for the first time that TLR2,
TLR4, MyD88 are essential for clearance of Brucella from the lung
following aerosol exposure. Although TLR2, TLR4 and MyD88
are not required for the development of cell-mediated adaptive
immunity, they play diverse roles in Brucella antigen specific anti-
body production and antibody class switching. The information
obtained from this study will greatly facilitate efforts to under-
stand immunity to Brucella and the rational design of novel
vaccines against Brucella infection.
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